Detail akcie Takeda Pharmactl Depository Receipt online

Business Summary: Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2024, Takeda Pharmaceutical Co Ltd (ADR) revenues increased 6% to Y4.264T. Net income decreased 55% to Y144.07B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Amortization and Impairment Losses on Pr increase of 20% to Y652.12B (expense), Research and development expenses increase of 15% to Y729.92B (expense).